GUANGZHOU LBP MEDICINE SCIENCE & TECHNOLOGY CO., LTD.

Guangzhou LBP Medicine Science & Technology Co., Ltd.

Equities

688393

CNE1000043R4

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
18 ^CNY	+4.23%		+10.70%	-27.91%

Apr. 23	LBP Medicine Scraps Convertible Bonds Issuance Plans	MT
Apr. 19	LBP Medicine Gets Certificate for HER2 Antibody Reagent	MT

LBP Medicine Science & Technology Co., Ltd has completed an IPO in the amount of CNY 713.2704 million.

August 12, 2020 at 12:00 am EDT

LBP Medicine Science & Technology Co., Ltd has completed an IPO in the amount of CNY 713.2704 million. Security Name: A Shares Security Type: Common Stock Securities Offered: 23,340,000 PriceRange: CNY 30.56 Transaction Features: Sponsor Backed Offering

Latest news about Guangzhou LBP Medicine Science & Technology Co., Ltd.

LBP Medicine Scraps Convertible Bonds Issuance Plans	Apr. 23	MT
LBP Medicine Gets Certificate for HER2 Antibody Reagent	Apr. 19	MT
Guangzhou LBP Medicine Science & Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 23	CI
Guangzhou LBP Medicine Science & Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Certain A Shares of LBP Medicine Science & Technology Co., Ltd are subject to a Lock-Up Agreement Ending on 20-AUG-2023.	23-08-20	CI
Guangzhou LBP Medicine Science & Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-14	CI
Guangzhou LBP Medicine Science & Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Guangzhou LBP Medicine Science & Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-24	CI
Guangzhou LBP Medicine Science & Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Guangzhou LBP Medicine Science & Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25	CI
Guangzhou LBP Medicine Science & Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
Guangzhou LBP Medicine Science & Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-24	CI
Guangzhou LBP Medicine Science & Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-27	CI
Guangzhou Anbiping Medical Laboratory Co., Ltd. announced that it expects to receive CNY 20 million in funding from Guangzhou LBP Medicine Science & Technology Co., Ltd., Guangzhou Anbiping No. 1 Investment Partnership Enterprise (Limited Partnership), Guangzhou Anbiping No. 2 Investment Partnership Enterprise (Limited Partnership)	21-09-22	CI
Guangzhou Lbp Medicine Science & Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-24	CI
Guangzhou LBP Medicine Science & Technology Co., Ltd.(SHSE:688393) added to Shanghai Stock Exchange Composite Index	21-08-20	CI
Guangzhou LBP Medicine Science & Technology Co., Ltd.(SHSE:688393) added to Shanghai Stock Exchange A Share Index	21-08-20	CI
Certain A Shares of LBP Medicine Science & Technology Co., Ltd are subject to a Lock-Up Agreement Ending on 20-AUG-2021.	21-08-19	CI
Guangzhou LBP Medicine Science & Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-27	CI
Guangzhou Lbp Medicine Science & Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-13	CI
Guangzhou LBP Medicine Science & Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-02-24	CI
Guangzhou LBP Medicine Science & Technology Co., Ltd. Reports Earnings Results for the First Three Quarters of 2020	20-10-20	CI
LBP Medicine Science & Technology Co., Ltd has completed an IPO in the amount of CNY 713.2704 million.	20-08-12	CI
LBP Medicine Science & Technology Co., Ltd has filed an IPO.	19-12-20	CI
LBP Medicine Science & Technology Co., Ltd announced that it has received funding from ShenZhen GTJA Investment Group Co., Ltd	17-07-31	CI

Chart Guangzhou LBP Medicine Science & Technology Co., Ltd.

Duration

Period

Chart Guangzhou LBP Medicine Science & Technology Co., Ltd.

More charts

Company Profile

Guangzhou LBP Medicine Science & Technology Co Ltd is a China-based company mainly engaged in the research, development, production and sales of in vitro diagnostic reagents and instruments. The Companyâs main products are pathological diagnostic reagents and instruments, covering three major technology platforms for cytological diagnosis, molecular diagnosis and immunodiagnosis, including LBP series, IHC series, PCR series and FISH series, such as integrated slide and dyeing machine, liquid-based cell and microorganism processing, preservation reagents, automatic nucleic acid molecular hybridization instrument, automatic slide processing system and immunochromogenic reagents, etc. Its products are mainly used in pathological diagnosis of tumors. The Company operates its businesses within the domestic market and to overseas markets.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-21 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
GUANGZHOU LBP MEDICINE SCIENCE & TECHNOLOGY CO., LTD.	-27.91%	232M
BIOMÉRIEUX	+1.29%	12.8B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-10.29%	7.61B
DIASORIN S.P.A.	+3.58%	5.41B
AUTOBIO DIAGNOSTICS CO., LTD.	-1.16%	4.51B
LANTHEUS HOLDINGS, INC.	+5.74%	4.49B
ANDON HEALTH CO., LTD.	+12.21%	2.73B
VITROLIFE AB	-14.18%	2.02B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-11.50%	1.73B
MYRIAD GENETICS, INC.	-5.02%	1.64B

Diagnostic & Testing Substances